PRESS STATEMENTS01.26.2021 Statement on ATMI Ranking01.20.2021 Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture01.15.2021 Statement by Pfizer Chairman and CEO Albert Bourla01.15.2021 Statement on European Upscaling as well as Impact on Deliveries01.08.2021 An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation Associated with Rapid Transmission12.17.2020 Pfizer Update on COVID-19 Vaccine Distribution12.15.2020 Pfizer Doses First Participants as Part of Global Achondroplasia Phase 2 Development Program12.09.2020 Statement on EMA Cyberattack12.01.2020 Pfizer and BioNTech Submitted Application for Conditional Marketing Authorization for COVID-19 Vaccine to the EMA11.20.2020 Pfizer Receives European Approval for Oncology Supportive Care Biosimilar, NYVEPRIA™ (pegfilgrastim)11.16.2020 Pfizer Update On Our U.S. COVID-19 Vaccine Candidate Distribution Preparedness11.10.2020 Pfizer Statement on Geodon (ziprasidone) Trial Closure in the United States10.29.2020 New Report Identifies Need for More Effective Policy Responses and Investment to Prevent Strokes in Europe10.14.2020 Pfizer and BioNTech Announce New England Journal of Medicine Publication of Phase 1 Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-1909.30.2020 BioNTech and Pfizer Announce Nature Publication of German Phase 1/2 Study Data from mRNA-based Vaccine Candidate BNT162b1 Against SARS-CoV-208.17.2020 Pfizer Statement on Lyrica (Pregabalin) Patent Infringement in Japan08.12.2020 Pfizer and BioNTech Announce Publication of Peer-Reviewed Data from Ongoing Phase 1/2 study of mRNA-based Vaccine Candidate, BNT162b1, Against SARS-CoV-2 in Nature08.06.2020 Pfizer signs on to The Hispanic Promise further strengthening its ties and commitment to Hispanics in the workplace08.05.2020 The Bristol-Myers Squibb-Pfizer Alliance is pleased with the U.S. District Court decision to uphold both the composition of matter (COM) patent (US 6,967,208) and formulation patent (US 9,326,945) covering Eliquis®.07.22.2020 Pfizer Shares Pre-Clinical Data Updates on COVID-19 Antiviral Research ProgramPaginationFirst page« FirstPrevious page‹ Previous Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7Next pageNext ›Last pageLast »Press Release ArchivePress StatementsPodcastsThe Antigen PodcastThe Antigen Podcast Season 1The Antigen Podcast Episode 1: Vaccines 101The Antigen Podcast Episode 2: The History of VaccinesThe Antigen Podcast Episode 3: Global Perspectives, Barriers & SolutionsThe Antigen Podcast Episode 4: Vaccine Hesitancy Part 1The Antigen Podcast Episode 5: Vaccine Hesitancy Part 2The Antigen Podcast Episode 6: Vaccine Politics, Policy & AdvocacyThe Antigen Podcast Episode 7: Innovations in the Vaccine LandscapeThe Antigen Podcast Episode 8: What's Next?The Antigen Podcast Season 2The Antigen Podcast Episode 1: #COVID19 Looking Back to Look ForwardThe Antigen Podcast Episode 2: #COVID19 What Do We Do in the Meantime?The Antigen Podcast Episode 3: #COVID19 The Quest for a VaccineThe Antigen Podcast Episode 4: #COVID19 Teamwork Makes the Dream WorkDiverse Perspectives Podcastmenopause: unmutedHemcastContact Media RelationsPress Kits & DownloadsCompany Press KitPfizer Oncology Press KitPSA NarrativeRA NarRAtiveRare Disease Gene Therapy Press KitATTR-Amyloidosis Press KitUC NarrativeEczema Inside Out Press KitOnline Pfizer Press KitCompany Press KitView the Pfizer Company Press KitPress StatementsView Pfizer's latest press statements Related ArticlesOur PeopleThanking John Young for His Years of Service to Pfizer – and to…Our PurposeIncreased Access to Biosimilars Could Save the U.S. Healthcare…Your HealthTranslating Technical Language into Plain Language for Clinical…Our PurposeHow 10 Biopharma Companies are Working Together to Bring…Our PeopleView for the FutureYour HealthA "Ticklist" For Staying Safe While Spending Time…Your HealthHealth Screenings Every African American Man Should KnowOur SciencemRNA – Technology at the Forefront During Global PandemicYour HealthEmpowering Patients by Closing the Health Literacy GapOur PurposeMaking a Global Impact in Breast Cancer CareYour HealthAre You Familiar with AFib Symptoms and the Increased Risk of…Your HealthIn Their Words: Five People with Ulcerative Colitis Speak Up…Our PurposeDoing Better: Increasing Diversity in Clinical TrialsOur PurposePartnering to RETHINK Vaccine Confidence and RE:SET Mental…Our PurposeImproving Metastatic Breast Cancer Care for Underserved…Our ScienceAn Open Letter from Pfizer Chairman and CEO to ColleaguesOur PurposeReimagining Primary Healthcare in Bogor, IndonesiaOur PurposeSupporting India in Its Time of NeedOur PeopleMeet Dacia Young, a Senior Scientist within the Vaccine Research…Our PurposeWisconsin is Ready for CuresYour HealthIn His Shoes (or Hiking Boots): William’s epic solo adventure to…ShowHide
